Pantoprazole Sodium for Injection, 40 mg Vial
GastrointestinalEssential, 95% service targetPrimary vendor Harborline Pharmaceuticals, lead 1 day, ordered every 3 days00143928410
Stock position
- On hand
- 8,916 vial178.3 days of supply
- On order
- 69 vialfirst arrives Mon Sep 14
- Forecast rate
- 50.0 vial/daynext 30 days
- Demand over 4 days
- 215 viallead time plus review period
- Safety stock
- 39 vialempirical 95th percentile of forecast error
- Reorder point
- 254 vialabove
- Stockout
- not projected
- Recommended order
- none
- Inventory value
- $24,965at $2.80 per vial
How the forecast was made
Exponential smoothing10% weekly error, under-forecast29% better than naive
A weighted recent average that learns the weekday pattern and any trend. Recent days count more than old ones.
Report card: the model was fit on history up to Tue Jul 21 and scored on the 56 days after. Weekly totals were off by 10% on average (25% day by day), and it under-forecast by 4% overall. A same-weekday-last-week guess would have been off by 14%.
actual forecast, 80% and 95% range what the model said during the report card windowvial/day
Projected on hand, vial: today's stock plus open orders on their expected dates, minus the forecast, day by day.
Lots and expiry
Earliest-expiry-first simulation against the forecast. Waste is what remains in a lot on its expiry date.
| Lot | Quantity | Expires | Days | Unit cost | Projected waste |
|---|---|---|---|---|---|
| L00103 | 8,916 | Thu Feb 3 | 507 | $2.80 | 0 vial · $0 |
Vendors and prices, last 90 days
| Vendor | Part number | Vendor description | Sells by | Paid per vial | Invoices | 90-day spend | Pairing |
|---|---|---|---|---|---|---|---|
| Harborline Pharmaceuticals | 00143928410 | PANTOPRAZOLE NA 40 MG/1 VIAL EA | EA of 1 | $2.83 | 32 | $9,795 | stand-in |
| Cobalt Rx Distributors | CRX-21656 | PANTOP 40MG/1 SDV 1CT | EA of 1 | $2.65 | 14 | $3,937 | stand-in |
Harborline Pharmaceuticals charges $2.8292 per vial for this item; Cobalt Rx Distributors charges $2.6496. That is 7% more on about 14,040 vial a year, or $2,521 a year. No contract is on file for this Harborline Pharmaceuticals line.